University of Santiago de Compostela   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Santiago de Compostela Spain (1495)

Organization Overview

First Clinical Trial
2010
NCT02150031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Centre for the Development of Industrial Technology (CDTI) | Clinic University Hospital of Santiago, Santiago de Compostela, Spain. | Hospital Clinico Universitario de Santiago | Jesús R. Requena | Juan Blanco Carrión | Senior lecturer at the University of Santiago de Compostela | Senior lecturer at University of Santiago de Compostela | Universidad de Santiago de Compostela | University Clinical Hospital of Santiago de Compostela | University of Santiago de Compostela | University of Santiago de Compostela, Spain

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 2)

Bacteremia (Phase 4)

Dental Plaque (Phase 4)

Endocarditis (Phase 4)

Gingivitis (Phase 4)

Hyperkinesis (Phase 2)

Mucopolysaccharidoses (Phase 2)

Mucopolysaccharidosis III (Phase 2)

Oral Ulcer (Phase 4)

Peri-Implantitis (Phase 4)

Periodontitis (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 20
  • # of Trial APIs: 20